0001628280-24-023605.txt : 20240515 0001628280-24-023605.hdr.sgml : 20240515 20240515163656 ACCESSION NUMBER: 0001628280-24-023605 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240513 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schaeffer Orlov S Nicole CENTRAL INDEX KEY: 0001401017 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30739 FILM NUMBER: 24951911 MAIL ADDRESS: STREET 1: INSMED INCORPORATED STREET 2: 10 FINDERNE AVENUE CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSMED Inc CENTRAL INDEX KEY: 0001104506 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 541972729 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908-977-9900 MAIL ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: INSMED INC DATE OF NAME CHANGE: 20000128 4 1 wk-form4_1715805404.xml FORM 4 X0508 4 2024-05-13 0 0001104506 INSMED Inc INSM 0001401017 Schaeffer Orlov S Nicole 700 US 202/206 BRIDGEWATER NJ 08807 0 1 0 0 Chief People Strategy Officer 0 Common Stock 2024-05-13 4 A 0 13308 A 115268 D Common Stock 2024-05-14 4 S 0 6508 25.53 D 108760 D Stock Option (right to buy) 25.83 2024-05-13 4 A 0 65230 0 A 2034-05-13 Common Stock 65230 65230 D Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% percent on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. Each RSU was granted on May 13, 2024 for no consideration. Due to a clerical error related to the reporting of shares previously withheld by the Company to satisfy tax obligations upon the vesting of RSUs, this number was previously overstated by 24 shares. This value reflects the adjustment, decreasing the amount beneficially owned by 24 shares. Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees. This is the weighted average sales price representing 6,508 shares sold at prices ranging from $25.50 to $25.55 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the Initial Vesting Date. /s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact 2024-05-15